InscriptionConnexion
@Sainte tu as déjà été amoureuse ?
:Noted:
il y a un an
jouhn croit à la théorie des anciens astronautes il est juste fou
:sad2:
il y a un an
Elda
Elda
1 an
Je faisais référence à FranceSoir qui n'a pas cessé de formuler des prédictions apocalyptiques depuis le début, profitant de jouer sur les peurs pour mieux s'en mettre plein les poches. C'est juste dommage qu'il existe des gens comme Xoxo (sur ce sujet précis évidemment) pour se faire encore plumer même 4 ans après
:(
Pas compris je vois juste du soja qui dégouline , oublie pas ta 6e dose
:philunette:
il y a un an
x0x0
x0x0
1 an
Je confirme ça ne sert a rien, à chaque fois que tu l'ouvre tu prouve à quel point t'es un énorme homme soja quadrule dosé , si j'avais un peu moins de mépris j'aurais de la peine pour toi
:philunette:
On invective à défaut de pouvoir argumenter. Un grand classique
:risibo:
il y a un an
Elda
Elda
1 an
On invective à défaut de pouvoir argumenter. Un grand classique
:risibo:
Cocasse alors que tu es le premier à débarquer en étant méprisant comme tous les types de ton genre et en ignorant le post ou j'ai donné l'étude et la conclusion en te demandant ton avis
:philunette:
il y a un an
Elda
Elda
1 an
On invective à défaut de pouvoir argumenter. Un grand classique
:risibo:
C'est un naufrage srx...
il y a un an
Elda
Elda
1 an
Je faisais référence à FranceSoir qui n'a pas cessé de formuler des prédictions apocalyptiques depuis le début, profitant de jouer sur les peurs pour mieux s'en mettre plein les poches. C'est juste dommage qu'il existe des gens comme Xoxo (sur ce sujet précis évidemment) pour se faire encore plumer même 4 ans après
:(
Le mec a quand même liké son propre post
:jesus_moqueur:
il y a un an
x0x0
x0x0
1 an
@Sainte tu as déjà été amoureuse ?
:Noted:
c'est très secret
:rika:
il y a un an
Sainte
Sainte
1 an
jouhn croit à la théorie des anciens astronautes il est juste fou
:sad2:
Bah c'est réel les anciens astronautes non ?
:(
il y a un an
2sur10
2sur10
1 an
C'est un naufrage srx...
On attends aussi ton argumentaire sur l'étude qui montre l'arnaque vaccinale
:philunette:


Spoiler : tu va rien dire et te contenter de ton mépris et tes insultes habituelles car t'es une énorme merde
:philunette:
il y a un an
Sainte
Sainte
1 an
jouhn croit à la théorie des anciens astronautes il est juste fou
:sad2:
C'est vrai ?

Je viens de regarder c'est ridicule ce truc
:dujardin_sourire:
il y a un an
2sur10
2sur10
1 an
Bah c'est réel les anciens astronautes non ?
:(
bah non c'est ridicule et ça ne rime à rien
:(
il y a un an
T'es sûre qu'il te parlait pas de Stargate plutôt ?
:dujardin_sourire:
il y a un an
x0x0
x0x0
1 an
Attention à ne pas confondre l'incompétence et la corruption , même si la barrière est ténue...

La mauvaise gestion était en réalité une très bonne gestion de contrôle social de masse.

Pareil pour les injections il ne faut pas laisser passer cette arnaque www.francesoir.fr https://www.francesoir.fr[...]-19-et-un-effet-aggravant
France soir...

Je viens de lire l'étude, les effets aggravant ont eu lieu pour 65% des patients ayant eu un vaccin avant le covid + ayant eu le variant delta de celui ci peu après. Causant ainsi une accumulation de glycoprotéines pouvant provoquer des caillots sanguins
Mais aussi pour les + de 89 ans et certaines pathologies immunodéficientes
Elle explique que le vaccin n'a pas d'effet favorable contre les formes graves en dessous de 50 ans mais qu'il a eu une certaine efficacité positive dans la réduction des admissions en USI ou des décès, via un effet antiviral non stérilisant des anticorps et qu'il est à privilégier pour les 50 à 90 ans.

C'est ça aussi le problème, un article super intéressant qui soulève des questions pertinentes sur comment mieux gérer une campagne de vaccination, comment trouver des alternatives et le fait de ne pas cacher les effets indésirables ou décès est transformé en : Le vaccin n'a que des effets négatifs pour tout le monde


The negative interactions can be explained by combining

the following insights: (a) the spike glycoprotein from

both the SARS-CoV-2 virus and from COVID-19 vaccines

has many known mechanisms of toxicity [25,26] and it is

responsible for the formation of microscopic blood clots in the

lung capillaries and alveoli [27-29] that result in the oxygen

desaturation responsible for most hospitalizations and deaths;

(b) the spike protein is known to persist in the human body

for at least 15 months, if not longer [30], and experimental

treatment protocols for removing it from the body have only

just started being explored [31,32]. Because the spike protein

has also been used as the antigen for the genetic COVID-19

vaccines, vaccination followed with a breakthrough infection,

within close temporal proximity of a few months, could result

in excess bio-accumulation of spike protein. Thus, although

the vaccine appears have some positive efficacy towards

the reduction of ICU admissions or deaths, via some nonsterilizing antiviral effect of vaccine induced antibodies

averaged over the entire cohort, for those patients where this

antiviral response fails to mitigate an infection, the greater

cumulative load of spike protein from both infection and

prior vaccination, can explain the unfavorable interaction

between vaccination and severity of the disease. It can also

explain why the vaccine has similar negative interactions

for fragile patients with age > 89 years and patients with

immunodeficiency, where the elicited antibody response may

be insufficient, resulting in no antiviral protection but some

harm due to excess accumulation of the spike protein.

It is indisputable that both HCQ-AZ and vaccination

exhibit efficacy independently in multivariate analysis with

a sufficiently improved survival benefit for the category

of age ≥ 50 years to preclude doubts on the reality of the

measurement, especially for HCQ-AZ that has been severely

criticized and denied. Somehow ironically, HCQ-AZ and

vaccination shared a similar fate in the analysis of the IHUMéditerranée cohort. Because their ORs were close and the

calculation data suffered from the same imperfection for both

of them (see results for HCQ-AZ in article Part 1 of our study,

[14]), if the analysis was deemed not valid for HCQ-AZ it

should be deemed not valid as well for vaccination and vice

versa.

This is quite embarrassing for the proponents of

vaccination as being the only valid response to the pandemic.

The approval conditions for a vaccine candidate under FDA

rule is that no alternative treatment exists for emergency

use authorisation (EUA). However the potential efficacy of

HCQ-AZ in Covid-19 was known to Glaxo and Pfizer as

early as March-May 2020 [33-35]. Furthermore, the Indian

Council of Medical Research (ICMR) had proposed, as early

as March 23, 2020, the prophylactic use of weekly low-dose

hydroxychloroquine as pre-exposure prophylaxis for healthcare workers [36], based on the biological plausibility of its

antiviral action against COVID-19. A meta-analysis [37] of

11 Indian studies that followed the ICMR protocol found an

infection ratio risk reduction with RR=0.56 (p=0.004), and for

the five studies that included only patients that followed the

ICMR protocol for at least 6 weeks, allowing for an optimal

buildup of hydroxychloroquine in the lungs, the infection ratio

risk reduction was RR=0.25 (p<0.001), which is comparable

with the infection ratio risk reduction efficacy claimed by

several COVID-19 vaccines on the market. The toxicity of

this experimental vaccination should be emphasized as well

as its association with a very large number of severe sideeffects and even deaths, worldwide, at least in countries with

a high vaccination coverage. Irreversible or long lasting

debilitations of all sorts are reported in a non-negligible

Forgot that inside the icon there's still a young girl from
:Purer:
il y a un an
x0x0
x0x0
1 an
Cocasse alors que tu es le premier à débarquer en étant méprisant comme tous les types de ton genre et en ignorant le post ou j'ai donné l'étude et la conclusion en te demandant ton avis
:philunette:
TU DONNES UNE ÉTUDE OÙ LES AUTEURS SONT DES MEMBRES DE FRANCESOIR

Dans la publication il y a littéralement leur directeur alors qu'il n'est même pas scientifique. Publication qui d'ailleurs n'est pas publiée ailleurs que dans le propre journal de l'IHU. C'est quel niveau d'auto-sucage, sérieusement ?
:hap:
il y a un an
France soir...

Je viens de lire l'étude, les effets aggravant ont eu lieu pour 65% des patients ayant eu un vaccin avant le covid + ayant eu le variant delta de celui ci peu après. Causant ainsi une accumulation de glycoprotéines pouvant provoquer des caillots sanguins
Mais aussi pour les + de 89 ans et certaines pathologies immunodéficientes
Elle explique que le vaccin n'a pas d'effet favorable contre les formes graves en dessous de 50 ans mais qu'il a eu une certaine efficacité positive dans la réduction des admissions en USI ou des décès, via un effet antiviral non stérilisant des anticorps et qu'il est à privilégier pour les 50 à 90 ans.

C'est ça aussi le problème, un article super intéressant qui soulève des questions pertinentes sur comment mieux gérer une campagne de vaccination, comment trouver des alternatives et le fait de ne pas cacher les effets indésirables ou décès est transformé en : Le vaccin n'a que des effets négatifs pour tout le monde


The negative interactions can be explained by combining

the following insights: (a) the spike glycoprotein from

both the SARS-CoV-2 virus and from COVID-19 vaccines

has many known mechanisms of toxicity [25,26] and it is

responsible for the formation of microscopic blood clots in the

lung capillaries and alveoli [27-29] that result in the oxygen

desaturation responsible for most hospitalizations and deaths;

(b) the spike protein is known to persist in the human body

for at least 15 months, if not longer [30], and experimental

treatment protocols for removing it from the body have only

just started being explored [31,32]. Because the spike protein

has also been used as the antigen for the genetic COVID-19

vaccines, vaccination followed with a breakthrough infection,

within close temporal proximity of a few months, could result

in excess bio-accumulation of spike protein. Thus, although

the vaccine appears have some positive efficacy towards

the reduction of ICU admissions or deaths, via some nonsterilizing antiviral effect of vaccine induced antibodies

averaged over the entire cohort, for those patients where this

antiviral response fails to mitigate an infection, the greater

cumulative load of spike protein from both infection and

prior vaccination, can explain the unfavorable interaction

between vaccination and severity of the disease. It can also

explain why the vaccine has similar negative interactions

for fragile patients with age > 89 years and patients with

immunodeficiency, where the elicited antibody response may

be insufficient, resulting in no antiviral protection but some

harm due to excess accumulation of the spike protein.

It is indisputable that both HCQ-AZ and vaccination

exhibit efficacy independently in multivariate analysis with

a sufficiently improved survival benefit for the category

of age ≥ 50 years to preclude doubts on the reality of the

measurement, especially for HCQ-AZ that has been severely

criticized and denied. Somehow ironically, HCQ-AZ and

vaccination shared a similar fate in the analysis of the IHUMéditerranée cohort. Because their ORs were close and the

calculation data suffered from the same imperfection for both

of them (see results for HCQ-AZ in article Part 1 of our study,

[14]), if the analysis was deemed not valid for HCQ-AZ it

should be deemed not valid as well for vaccination and vice

versa.

This is quite embarrassing for the proponents of

vaccination as being the only valid response to the pandemic.

The approval conditions for a vaccine candidate under FDA

rule is that no alternative treatment exists for emergency

use authorisation (EUA). However the potential efficacy of

HCQ-AZ in Covid-19 was known to Glaxo and Pfizer as

early as March-May 2020 [33-35]. Furthermore, the Indian

Council of Medical Research (ICMR) had proposed, as early

as March 23, 2020, the prophylactic use of weekly low-dose

hydroxychloroquine as pre-exposure prophylaxis for healthcare workers [36], based on the biological plausibility of its

antiviral action against COVID-19. A meta-analysis [37] of

11 Indian studies that followed the ICMR protocol found an

infection ratio risk reduction with RR=0.56 (p=0.004), and for

the five studies that included only patients that followed the

ICMR protocol for at least 6 weeks, allowing for an optimal

buildup of hydroxychloroquine in the lungs, the infection ratio

risk reduction was RR=0.25 (p<0.001), which is comparable

with the infection ratio risk reduction efficacy claimed by

several COVID-19 vaccines on the market. The toxicity of

this experimental vaccination should be emphasized as well

as its association with a very large number of severe sideeffects and even deaths, worldwide, at least in countries with

a high vaccination coverage. Irreversible or long lasting

debilitations of all sorts are reported in a non-negligible

post
il y a un an
genre Pastèque ?
:surprised:
il y a un an
Elda
Elda
1 an
TU DONNES UNE ÉTUDE OÙ LES AUTEURS SONT DES MEMBRES DE FRANCESOIR

Dans la publication il y a littéralement leur directeur alors qu'il n'est même pas scientifique. Publication qui d'ailleurs n'est pas publiée ailleurs que dans le propre journal de l'IHU. C'est quel niveau d'auto-sucage, sérieusement ?
:hap:
pas malin vu qu'ils écrivent littéralement dans leur étude
It is indisputable that both HCQ-AZ and vaccination exhibit efficacy independently in multivariate analysis with a sufficiently improved survival benefit for the category of age ≥ 50 years
Forgot that inside the icon there's still a young girl from
:Purer:
il y a un an
France soir...

Je viens de lire l'étude, les effets aggravant ont eu lieu pour 65% des patients ayant eu un vaccin avant le covid + ayant eu le variant delta de celui ci peu après. Causant ainsi une accumulation de glycoprotéines pouvant provoquer des caillots sanguins
Mais aussi pour les + de 89 ans et certaines pathologies immunodéficientes
Elle explique que le vaccin n'a pas d'effet favorable contre les formes graves en dessous de 50 ans mais qu'il a eu une certaine efficacité positive dans la réduction des admissions en USI ou des décès, via un effet antiviral non stérilisant des anticorps et qu'il est à privilégier pour les 50 à 90 ans.

C'est ça aussi le problème, un article super intéressant qui soulève des questions pertinentes sur comment mieux gérer une campagne de vaccination, comment trouver des alternatives et le fait de ne pas cacher les effets indésirables ou décès est transformé en : Le vaccin n'a que des effets négatifs pour tout le monde


The negative interactions can be explained by combining

the following insights: (a) the spike glycoprotein from

both the SARS-CoV-2 virus and from COVID-19 vaccines

has many known mechanisms of toxicity [25,26] and it is

responsible for the formation of microscopic blood clots in the

lung capillaries and alveoli [27-29] that result in the oxygen

desaturation responsible for most hospitalizations and deaths;

(b) the spike protein is known to persist in the human body

for at least 15 months, if not longer [30], and experimental

treatment protocols for removing it from the body have only

just started being explored [31,32]. Because the spike protein

has also been used as the antigen for the genetic COVID-19

vaccines, vaccination followed with a breakthrough infection,

within close temporal proximity of a few months, could result

in excess bio-accumulation of spike protein. Thus, although

the vaccine appears have some positive efficacy towards

the reduction of ICU admissions or deaths, via some nonsterilizing antiviral effect of vaccine induced antibodies

averaged over the entire cohort, for those patients where this

antiviral response fails to mitigate an infection, the greater

cumulative load of spike protein from both infection and

prior vaccination, can explain the unfavorable interaction

between vaccination and severity of the disease. It can also

explain why the vaccine has similar negative interactions

for fragile patients with age > 89 years and patients with

immunodeficiency, where the elicited antibody response may

be insufficient, resulting in no antiviral protection but some

harm due to excess accumulation of the spike protein.

It is indisputable that both HCQ-AZ and vaccination

exhibit efficacy independently in multivariate analysis with

a sufficiently improved survival benefit for the category

of age ≥ 50 years to preclude doubts on the reality of the

measurement, especially for HCQ-AZ that has been severely

criticized and denied. Somehow ironically, HCQ-AZ and

vaccination shared a similar fate in the analysis of the IHUMéditerranée cohort. Because their ORs were close and the

calculation data suffered from the same imperfection for both

of them (see results for HCQ-AZ in article Part 1 of our study,

[14]), if the analysis was deemed not valid for HCQ-AZ it

should be deemed not valid as well for vaccination and vice

versa.

This is quite embarrassing for the proponents of

vaccination as being the only valid response to the pandemic.

The approval conditions for a vaccine candidate under FDA

rule is that no alternative treatment exists for emergency

use authorisation (EUA). However the potential efficacy of

HCQ-AZ in Covid-19 was known to Glaxo and Pfizer as

early as March-May 2020 [33-35]. Furthermore, the Indian

Council of Medical Research (ICMR) had proposed, as early

as March 23, 2020, the prophylactic use of weekly low-dose

hydroxychloroquine as pre-exposure prophylaxis for healthcare workers [36], based on the biological plausibility of its

antiviral action against COVID-19. A meta-analysis [37] of

11 Indian studies that followed the ICMR protocol found an

infection ratio risk reduction with RR=0.56 (p=0.004), and for

the five studies that included only patients that followed the

ICMR protocol for at least 6 weeks, allowing for an optimal

buildup of hydroxychloroquine in the lungs, the infection ratio

risk reduction was RR=0.25 (p<0.001), which is comparable

with the infection ratio risk reduction efficacy claimed by

several COVID-19 vaccines on the market. The toxicity of

this experimental vaccination should be emphasized as well

as its association with a very large number of severe sideeffects and even deaths, worldwide, at least in countries with

a high vaccination coverage. Irreversible or long lasting

debilitations of all sorts are reported in a non-negligible

Ce que tu viens de dire est bien écrit dans l'article ou il est fait mention de la différence > et < 50 ans
:Mouais_Jesus:


Du coup en dehors du fait que vous avez tous des réactions de golem avec france soir alors que c'est le seul journal qui a défendu nos libertés pendant le délire covid, on est d'accord sur le fond c'est le principal
il y a un an
x0x0
x0x0
1 an
Attention à ne pas confondre l'incompétence et la corruption , même si la barrière est ténue...

La mauvaise gestion était en réalité une très bonne gestion de contrôle social de masse.

Pareil pour les injections il ne faut pas laisser passer cette arnaque www.francesoir.fr https://www.francesoir.fr[...]-19-et-un-effet-aggravant
Ayaaaaa ça link France soir le journal de complotin
:sn44k:
:alergie:
:espagne:
il y a un an